Evidence map›Paper›PMID 41629687›Full record

ReviewCurrent cardiology reports2026

Optimizing Care in Pulmonary Embolism with the Pulmonary Embolism Response Team.

Bryan Kindya, Wissam Jaber

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current cardiology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bryan KindyaEmory University School of Medicine, Atlanta, GA, Georgia.
Wissam JaberEmory University School of Medicine, Atlanta, GA, Georgia. wissam.jaber@emory.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePulmonary embolism (PE) remains a commonly encountered condition with high morbidity and mortality associated with it. With the advent of more advanced interventional devices and techniques, there now exists the opportunity to offer intermediate and high-risk patients treatment above anticoagulation alone. The creation of pulmonary embolism response teams has served as an opportunity for multidisciplinary assessment of patients on an individual basis to help determine optimal treatment modality. Here we will review the composition of these teams, the service they provide, and review existing data for advanced treatment of PE. Recent findings: Recent reviews have suggested that the specialized assessment a pulmonary embolism response team can be associated with lower mortality from PE. In parallel with this, several recently published studies have investigated the use of catheter directed lysis and catheter based thrombectomy for intermediate and high risk patients, and found varying degrees of improved clinical outcomes in these populations. RECENT

findingsRecent reviews have suggested that the specialized assessment a pulmonary embolism response team can be associated with lower mortality from PE. In parallel with this, several recently published studies have investigated the use of catheter directed lysis and catheter based thrombectomy for intermediate and high risk patients, and found varying degrees of improved clinical outcomes in these populations. Pulmonary embolism response teams offer an individualized, multidisciplinary assessment of patients presenting with pulmonary embolism. With the newly published and continuously evolving data surrounding interventional based pulmonary embolism techniques, these teams and techniques have the opportunity to reduce the morbidity and mortality surrounding this disease.

Indexed as

Patient Care TeamPulmonary EmbolismThrombectomyThrombolytic TherapyAnticoagulantsHumansAnticoagulantsCatheter directed lysisPERTPulmonary embolismThrombectomy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.